| Description | Sutimlimab is a novel monoclonal antibody targeting complement protein C1. Sutimlimab is commonly used as a C1 inhibitor to treat cold agglutina-associated hemolysis. |
| molecular weight | N/A |
| CAS | 2049079-64-1 |
| Storage | store at low temperature | store at -80°C |
| References | 1. Alexander Röth, et al. Sutimlimab in Cold Agglutinin Disease. N Engl J Med. 2021 Apr 8;384(14):1323-1334. |